Bioheart Inc (BHRT.PK)

BHRT.PK on OTC Markets Group

0.02USD
18 Sep 2014
Price Change (% chg)

$-0.00 (-1.22%)
Prev Close
$0.02
Open
$0.02
Day's High
$0.02
Day's Low
$0.02
Volume
7,015
Avg. Vol
1,278,886
52-wk High
$0.08
52-wk Low
$0.01

BHRT.PK

Chart for BHRT.PK

About

Bioheart, Inc. is a development-stage, biotechnology company. The Company focuses on the discovery, development and commercialization of autologous cell therapies for the treatment of chronic and acute heart damage and peripheral vascular disease. MyoCell is a clinical muscle-derived cell therapy designed to populate regions of... (more)
No analyst recommendations are available for BHRT.PK.

Overall

Beta: 1.67
Market Cap (Mil.): $12.41
Shares Outstanding (Mil.): 517.27
Dividend: --
Yield (%): --

Financials

  BHRT.PK Industry Sector
P/E (TTM): -- 145.48 33.86
EPS (TTM): -0.01 -- --
ROI: -- -2.05 17.39
ROE: -- -6.87 18.25
Search Stocks

Earnings vs. Estimates

No consensus analysis data available.

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Wright Reports
$75.00
Provider: GlobalData
$125.00
Provider: GlobalData
$125.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks